Today we are happy to talk about our aaia-member PUSH Venture investing in the startup Allcyte.
PUSH Ventures is an early stage venture capital firm investing in outstanding teams with convincing products and high growth potential. Since 2012 they have been active as investors and entrepreneurs. They strongly believe in the megatrend of digitalisation and all kinds of technological advances in order to create value and that there are opportunities to solve existing problems in a better way with the help of technology.
Their initial investments are typically at pre-seed or seed stage with the potential to follow-on. We are industry-agnostic. Our target markets are Austria & Germany and outside of our target markets we are open to opportunistic investments.
The three-year old company Allcyte is a startup from Vienna that wants to revolutionize cancer treatment by using artificial intelligence and rapid lab tests to find the most promising medicine for each individual patient.